Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510699, China; Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Biomed Pharmacother. 2024 Nov;180:117561. doi: 10.1016/j.biopha.2024.117561. Epub 2024 Oct 13.
Broussonetia papyrifera (L.) L'Hér. ex Vent (B. papyrifera) is a deciduous tree widely distributed in Asia. Previous studies have revealed that leaves of B. papyrifera ameliorated atopic dermatitis (AD)-like symptoms and inflammatory response. However, the impact and underlying mechanism of other parts of B. papyrifera on AD remain elusive.
The AD mice induced by 1-Chloro-2,4-dinitrochlorobenzene were used to observe the histopathological alterations in the skin tissues using hematoxylin-eosin staining and toluidine blue staining techniques. Serum levels of inflammatory factors were quantified utilizing ELISA. Pyroptosis was analyzed by lactate dehydrogenase release and flow cytometry in human keratinocytes. The activation of Nod-like receptor protein 3 (NLRP3) inflammasome was analyzed by western blots. Furthermore, the mechanism underlying the inhibition of NLRP3 inflammasome by N-butanol extracts of B. papyrifera root bark (NE-BPRB) was investigated using cellular thermal shift assay and surface plasmon resonance techniques.
Treatment with NE-BPRB significantly ameliorated symptoms of AD mice and reduced serum levels of pro-inflammatory factors. NE-BPRB intervention exhibited inhibitory effects on NLRP3 inflammasome activation and pyroptosis in vitro and in vivo. NE-BPRB and its primary bioactive constituent chlorogenic acid (CA) promote the K48-linked ubiquitination of NLRP3, leading to its proteasomal degradation by binding WW domain containing E3 ubiquitin protein ligase 1 (WWP1).
The NE-BPRB and its primary bioactive constituent, CA, effectively inhibit the formation of the NLRP3 inflammasome and impede cell pyroptosis by promoting K48-linked ubiquitin-dependent proteasomal degradation of NLRP3 through binding to the E3 ubiquitin ligase WWP1, thereby resulting in improved AD.
构树( Broussonetia papyrifera (L.) L'Hér. ex Vent)是一种广泛分布于亚洲的落叶乔木。先前的研究表明,构树叶子可以改善特应性皮炎(AD)样症状和炎症反应。然而,构树其他部位对 AD 的影响和潜在机制仍不清楚。
使用 1-氯-2,4-二硝基氯苯诱导 AD 小鼠,通过苏木精-伊红染色和甲苯胺蓝染色技术观察皮肤组织的组织病理学改变。利用 ELISA 定量测定血清中炎症因子的水平。通过人角质形成细胞中乳酸脱氢酶释放和流式细胞术分析细胞焦亡。通过 Western blot 分析 Nod 样受体蛋白 3(NLRP3)炎性体的激活。此外,通过细胞热转移分析和表面等离子体共振技术研究构树根皮正丁醇提取物(NE-BPRB)抑制 NLRP3 炎性体的机制。
NE-BPRB 治疗可显著改善 AD 小鼠的症状,降低血清中促炎因子的水平。NE-BPRB 干预对 NLRP3 炎性体的激活和体外及体内的细胞焦亡均有抑制作用。NE-BPRB 及其主要生物活性成分绿原酸(CA)通过与含有 WW 结构域的 E3 泛素蛋白连接酶 1(WWP1)结合,促进 NLRP3 的 K48 连接泛素化,导致其通过蛋白酶体降解。
NE-BPRB 和其主要生物活性成分 CA 通过促进 NLRP3 的 K48 连接泛素化依赖性蛋白酶体降解,与 E3 泛素连接酶 WWP1 结合,有效抑制 NLRP3 炎性体的形成,阻止细胞焦亡,从而改善 AD。